GD
Roles
Takeda Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TAK-755 (rADAMTS13) | Congenital Thrombotic Thrombocytopenic Purpura (cTTP) | Phase 3 |
| TAK-861 | Narcolepsy Type 1 (NT1) | Phase 3 |
| TAK-279 (NDI-034858) | Moderate-to-Severe Plaque Psoriasis | Phase 3 |
| Soticlestat (TAK-935) | Dravet Syndrome, Lennox-Gastaut Syndrome | Phase 3 |
| TAK-676 + pembrolizumab | Solid Tumors | Phase 1/2 |
| TAK-500 | Solid Tumors | Phase 1/2 |
| TAK-186 (Goreisan) | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 2 |
| TAK-671 | Acute Pancreatitis | Phase 2 |